{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:44:56Z","timestamp":1784616296367,"version":"3.55.0"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103548"],"award-info":[{"award-number":["P20GM103548"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103620"],"award-info":[{"award-number":["P20GM103620"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0176526","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T17:34:19Z","timestamp":1493746459000},"page":"e0176526","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies"],"prefix":"10.1371","volume":"12","author":[{"given":"Ryan D.","family":"Geraets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-2099","authenticated-orcid":true,"given":"Logan M.","family":"Langin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0230-9979","authenticated-orcid":true,"given":"Jacob T.","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-8543","authenticated-orcid":false,"given":"Camille M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Beraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4320-4471","authenticated-orcid":true,"given":"Attila D.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/GIM.0b013e318211a7e1","article-title":"Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals","volume":"13","author":"RY Wang","year":"2011","journal-title":"Genetics in medicine: official journal of the American College of Medical Genetics"},{"issue":"3","key":"ref2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"PJ Meikle","year":"1999","journal-title":"JAMA"},{"key":"ref3","article-title":"Gene Therapy for the Neurological Manifestations in Lysosomal Storage Disorders","author":"SH Cheng","year":"2014","journal-title":"Journal of Lipid Research"},{"issue":"4","key":"ref4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","article-title":"Lysosomal disorders: from storage to cellular damage","volume":"1793","author":"A Ballabio","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrn1725","article-title":"Storage solutions: treating lysosomal disorders of the brain","volume":"6","author":"M Jeyakumar","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1750-3639.2004.tb00500.x","article-title":"The genetic spectrum of human neuronal ceroid-lipofuscinoses","volume":"14","author":"SE Mole","year":"2004","journal-title":"Brain Pathol"},{"issue":"4","key":"ref7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"A Jalanko","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"ref8","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","article-title":"The neuronal ceroid-lipofuscinoses: a historical introduction","volume":"1832","author":"M Haltia","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"ref9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/0883073813494268","article-title":"Classification and natural history of the neuronal ceroid lipofuscinoses","volume":"28","author":"JW Mink","year":"2013","journal-title":"Journal of child neurology"},{"issue":"10","key":"ref10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bbadis.2006.05.006","article-title":"Molecular genetics of the NCLs\u2014status and perspectives","volume":"1762","author":"E Siintola","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"ref11","first-page":"444","article-title":"The neuronal ceroid lipofuscinoses (Batten disease)","volume":"xxx","author":"SE Mole","year":"2011"},{"issue":"11","key":"ref12","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","article-title":"NCL diseases\u2014clinical perspectives","volume":"1832","author":"A Schulz","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"ref13","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"SE Mole","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"ref14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","article-title":"New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses","volume":"79","author":"RE Williams","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"ref15","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","article-title":"Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses","volume":"1832","author":"V Warrier","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/B978-0-444-59565-2.00038-1","article-title":"Neuronal ceroid lipofuscinoses","volume":"113","author":"B Chabrol","year":"2013","journal-title":"Handbook of clinical neurology"},{"issue":"2","key":"ref17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00019052-200304000-00001","article-title":"Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis","volume":"16","author":"JD Cooper","year":"2003","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"ref18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","article-title":"Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses","volume":"6","author":"SE Mole","year":"2005","journal-title":"Neurogenetics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13023-016-0414-2","article-title":"Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis","volume":"11","author":"RD Geraets","year":"2016","journal-title":"Orphanet journal of rare diseases"},{"issue":"10","key":"ref20","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.bbadis.2015.04.026","article-title":"Experimental therapies in the neuronal ceroid lipofuscinoses","volume":"1852","author":"NJ Neverman","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"M Kousi","year":"2012","journal-title":"Hum Mutat"},{"key":"ref22","unstructured":"Mole SE. NCL Resource 2014 [updated 05\/10\/2014]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ucl.ac.uk\/ncl\/mutation.shtml\" xlink:type=\"simple\">http:\/\/www.ucl.ac.uk\/ncl\/mutation.shtml<\/ext-link>."},{"key":"ref23","article-title":"The novel Cln1R151X mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy","author":"JN Miller","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinchem\/46.7.1005","article-title":"Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays","volume":"46","author":"I Sohar","year":"2000","journal-title":"Clin Chem"},{"issue":"13","key":"ref25","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/hmg\/ddt120","article-title":"The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis","volume":"22","author":"JN Miller","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"4","key":"ref26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/mgme.1999.2809","article-title":"A rapid fluorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL","volume":"66","author":"OP van Diggelen","year":"1999","journal-title":"Mol Genet Metab"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/srep02116","article-title":"Location- and sex-specific differences in weight and motor coordination in two commonly used mouse strains","volume":"3","author":"AD Kovacs","year":"2013","journal-title":"Sci Rep"},{"issue":"1\u20133","key":"ref28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"M Bourin","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"ref29","first-page":"18","article-title":"Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests","volume":"835","author":"JN Crawley","year":"1999","journal-title":"Brain Res"},{"issue":"5","key":"ref30","doi-asserted-by":"publisher","first-page":"e0128007","DOI":"10.1371\/journal.pone.0128007","article-title":"Abbreviated exposure to hypoxia is sufficient to induce CNS dysmyelination, modulate spinal motor neuron composition, and impair motor development in neonatal mice","volume":"10","author":"JO Watzlawik","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"ref31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.molmed.2006.06.001","article-title":"Stop-codon read-through for patients affected by a lysosomal storage disorder","volume":"12","author":"DA Brooks","year":"2006","journal-title":"Trends Mol Med"},{"issue":"4","key":"ref32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1242\/dmm.018804","article-title":"Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender","volume":"8","author":"AD Kovacs","year":"2015","journal-title":"Dis Model Mech"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnen\/62.1.1","article-title":"The neuronal ceroid-lipofuscinoses","volume":"62","author":"M Haltia","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"ref34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.bbadis.2006.06.010","article-title":"The neuronal ceroid-lipofuscinoses: from past to present","volume":"1762","author":"M Haltia","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"ref35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.bbadis.2006.08.002","article-title":"Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis","volume":"1762","author":"JD Cooper","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1750-3639.2004.tb00502.x","article-title":"Selectivity and types of cell death in the neuronal ceroid lipofuscinoses","volume":"14","author":"HM Mitchison","year":"2004","journal-title":"Brain Pathol"},{"issue":"41","key":"ref37","first-page":"9117","article-title":"A Mouse Model of Classical Late-Infantile Neuronal Ceroid Lipofuscinosis Based on Targeted Disruption of the CLN2 Gene Results in a Loss of Tripeptidyl-Peptidase I Activity and Progressive Neurodegeneration","volume":"24","author":"David E. Sleat","year":"2004","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"ref38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainresbull.2012.03.003","article-title":"Mouse models of neuronal ceroid lipofuscinoses: useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics","volume":"88","author":"JJ Shacka","year":"2012","journal-title":"Brain Res Bull"},{"issue":"4","key":"ref39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"ME Lull","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"4","key":"ref40","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ajmg.1320420428","article-title":"Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)","volume":"42","author":"DN Palmer","year":"1992","journal-title":"Am J Med Genet"},{"issue":"10","key":"ref41","doi-asserted-by":"publisher","first-page":"6559","DOI":"10.1074\/jbc.M507336200","article-title":"Determination of the substrate specificity of tripeptidyl-peptidase I using combinatorial peptide libraries and development of improved fluorogenic substrates","volume":"281","author":"Y Tian","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"ref42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/oxfordjournals.jbchem.a022781","article-title":"Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase","volume":"128","author":"J Ezaki","year":"2000","journal-title":"J Biochem"},{"issue":"6","key":"ref43","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1046\/j.1471-4159.1999.0722573.x","article-title":"A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase","volume":"72","author":"J Ezaki","year":"1999","journal-title":"J Neurochem"},{"issue":"12","key":"ref44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ncpneuro0355","article-title":"Mechanisms of Disease: astrocytes in neurodegenerative disease","volume":"2","author":"NJ Maragakis","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"issue":"1","key":"ref45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","article-title":"Unfolding the role of protein misfolding in neurodegenerative diseases","volume":"4","author":"C Soto","year":"2003","journal-title":"Nat Rev Neurosci"},{"issue":"1\u20132","key":"ref46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.brainresrev.2009.11.004","article-title":"Neuroglia in neurodegeneration","volume":"63","author":"MT Heneka","year":"2010","journal-title":"Brain Res Rev"},{"issue":"2\u20133","key":"ref47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12035-010-8098-4","article-title":"Astrogliosis in CNS pathologies: is there a role for microglia?","volume":"41","author":"D Zhang","year":"2010","journal-title":"Mol Neurobiol"},{"issue":"9\u201310","key":"ref48","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1023\/A:1007677003387","article-title":"Glial fibrillary acidic protein: GFAP-thirty-one years (1969\u20132000)","volume":"25","author":"LF Eng","year":"2000","journal-title":"Neurochem Res"},{"issue":"43","key":"ref49","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1523\/JNEUROSCI.3579-11.2011","article-title":"The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis","volume":"31","author":"SL Macauley","year":"2011","journal-title":"J Neurosci"},{"issue":"2","key":"ref50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.brainres.2004.07.030","article-title":"Late onset neurodegeneration in the Cln3-\/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation","volume":"1023","author":"CC Pontikis","year":"2004","journal-title":"Brain Res"},{"issue":"3","key":"ref51","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.nbd.2005.05.018","article-title":"Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7\/8 knock-in mouse model of Batten disease","volume":"20","author":"CC Pontikis","year":"2005","journal-title":"Neurobiol Dis"},{"issue":"1","key":"ref52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12011","article-title":"Review: activation patterns of microglia and their identification in the human brain","volume":"39","author":"D Boche","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"ref53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","article-title":"Microglia: biology and pathology","volume":"119","author":"MB Graeber","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"1","key":"ref54","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.expneurol.2009.01.022","article-title":"Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse","volume":"217","author":"SL Macauley","year":"2009","journal-title":"Exp Neurol"},{"issue":"1","key":"ref55","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","article-title":"Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"25","author":"C Kielar","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"4","key":"ref56","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1750-3639.2004.tb00077.x","article-title":"Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activation","volume":"14","author":"J Tyynela","year":"2004","journal-title":"Brain Pathol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/neuro.08.014.2009","article-title":"Early-life programming of later-life brain and behavior: a critical role for the immune system","volume":"3","author":"SD Bilbo","year":"2009","journal-title":"Front Behav Neurosci"},{"issue":"Suppl A","key":"ref58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/ejpn.2000.0436","article-title":"Aminoglycoside-mediated suppression of nonsense mutations in late infantile neuronal ceroid lipofuscinosis","volume":"5","author":"DE Sleat","year":"2001","journal-title":"Eur J Paediatr Neurol"},{"issue":"5333","key":"ref59","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"DE Sleat","year":"1997","journal-title":"Science"},{"issue":"10","key":"ref60","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bbadis.2006.07.001","article-title":"Diagnosis of the neuronal ceroid lipofuscinoses: an update","volume":"1762","author":"RE Williams","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"ref61","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ymgme.2008.01.014","article-title":"Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis","volume":"94","author":"DE Sleat","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"Pt 5","key":"ref62","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/brain\/awt043","article-title":"A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferation","volume":"136","author":"F Mahmood","year":"2013","journal-title":"Brain"},{"issue":"3","key":"ref63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/hmg\/10.3.291","article-title":"Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation","volume":"10","author":"KM Keeling","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"4","key":"ref64","doi-asserted-by":"publisher","first-page":"e60478","DOI":"10.1371\/journal.pone.0060478","article-title":"Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression","volume":"8","author":"KM Keeling","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgme.2011.10.005","article-title":"The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse","volume":"105","author":"D Wang","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"3","key":"ref66","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ymgme.2013.12.007","article-title":"Long-term nonsense suppression therapy moderates MPS I-H disease progression","volume":"111","author":"G Gunn","year":"2014","journal-title":"Mol Genet Metab"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","article-title":"Therapeutics based on stop codon readthrough","volume":"15","author":"KM Keeling","year":"2014","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"14","key":"ref68","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1093\/nar\/gkw638","article-title":"Novel small molecules potentiate premature termination codon readthrough by aminoglycosides","volume":"44","author":"A Baradaran-Heravi","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"ref69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40259-016-0157-6","article-title":"Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs)","volume":"30","author":"K Nagel-Wolfrum","year":"2016","journal-title":"BioDrugs"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0176526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T19:36:09Z","timestamp":1602012969000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0176526"}},"subtitle":[],"editor":[{"given":"Thomas","family":"Langmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0176526","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]}}}